Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BEAM Beam Therapeutics Inc

23,21

-0,86 (-3,57%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:10

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Beam Therapeutics (NASDAQ:BEAM)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Beam Therapeutics Charts.

Beam Therapeutics (NASDAQ:BEAM)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Beam Therapeutics Charts.

News Beam Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 7 Juni 2024 (31 Minuten vor) • Edgar (US Regulatory)

Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
Donnerstag 30 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress
Dienstag 14 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
Mittwoch 8 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Dienstag 26 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Beam Therapeutics Inc News-Artikel

Euro vs US Dollar

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen